InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Chin Richard, 董事长兼首席执行官. Director active across 2 companies, notably Kindred Biosciences, Inc.. In total, 8 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €616k. History available since 16 June 2021. The latest transaction was disclosed on 27 August 2021 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Chin Richard is Chief Executive Officer. He is also a Director of Cytek Biosciences, Inc. and serves as Chief Executive Officer of Kindred Biosciences, Inc. The 7 known filings cover transactions recorded between 2021-06-17 and 2026-03-12, with EUR 14,064,670 of sales and EUR 0 of purchases in the recent filings tracked, and the most common transaction nature being option exercise.